Abstract
Seven transmembrane Receptors (7TMRs) transmit signals through changes in conformation; the binding of ligands to any site on the receptor has the potential to change the receptor conformation. Allosteric ligands are defined as those which bind to sites other than the one needed for the endogenous receptor agonist (neurotransmitters, hormones). Allosteric ligand function is saturable (comes to a finite magnitude when the allosteric site is fully occupied) and probe dependent (the effects vary with different co-binding ligands). Both direct effects on receptor conformation and the induced effect on endogenous ligands must be considered when describing allosteric ligands; this paper will describe the quantitative models available to characterize these allosteric effects in molecular terms which can then be used to predict allosteric effects in all systems.
Keywords: Allosteric modulation, allosteric antagonism, biased agonism, drug discovery, positive allosteric modulation efficacy, receptor theory
Current Topics in Medicinal Chemistry
Title:Allosteric Drugs and Seven Transmembrane Receptors
Volume: 13 Issue: 1
Author(s): Terry Kenakin
Affiliation:
Keywords: Allosteric modulation, allosteric antagonism, biased agonism, drug discovery, positive allosteric modulation efficacy, receptor theory
Abstract: Seven transmembrane Receptors (7TMRs) transmit signals through changes in conformation; the binding of ligands to any site on the receptor has the potential to change the receptor conformation. Allosteric ligands are defined as those which bind to sites other than the one needed for the endogenous receptor agonist (neurotransmitters, hormones). Allosteric ligand function is saturable (comes to a finite magnitude when the allosteric site is fully occupied) and probe dependent (the effects vary with different co-binding ligands). Both direct effects on receptor conformation and the induced effect on endogenous ligands must be considered when describing allosteric ligands; this paper will describe the quantitative models available to characterize these allosteric effects in molecular terms which can then be used to predict allosteric effects in all systems.
Export Options
About this article
Cite this article as:
Kenakin Terry, Allosteric Drugs and Seven Transmembrane Receptors, Current Topics in Medicinal Chemistry 2013; 13 (1) . https://dx.doi.org/10.2174/1568026611313010003
DOI https://dx.doi.org/10.2174/1568026611313010003 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The CX3C-Chemokine Fractalkine in Kidney Diseases
Mini-Reviews in Medicinal Chemistry Strategies to Avoid TAVI-related Acute Kidney Injury
Current Pharmaceutical Design Bilosomes: A Novel Approach to Meet the Challenges in Oral Immunization
Recent Patents on Drug Delivery & Formulation Erythropoietin and mTOR: A “One-Two Punch” for Aging-Related Disorders Accompanied by Enhanced Life Expectancy
Current Neurovascular Research Reduction of Sodium Intake is a Prerequisite for Preventing and Curing High Blood Pressure in Hypertensive Patients - Second Part: Guidelines
Current Hypertension Reviews Atherosclerosis, Degenerative Aortic Stenosis and Statins
Current Drug Targets Treating Cancer and No-Cancer Pain in Older and Oldest Old Patients
Current Pharmaceutical Design Ghrelin and Growth Hormone Secretagogues, Physiological and Pharmacological Aspect
Current Drug Discovery Technologies Resveratrol and Lifespan in Model Organisms
Current Medicinal Chemistry Editorial (Heart Failure: The Need for Global Health Perspective)
Current Cardiology Reviews Chemical Diversity of Grape Products, a Complex Blend of Bioactive Secondary Metabolites
The Natural Products Journal The Role of Apelins in the Physiology of the Heart
Protein & Peptide Letters Toxics of Tobacco Smoke and Cardiovascular System: From Functional to Cellular Damage
Current Pharmaceutical Design Cytotoxic and Radio-sensitizing Effects of Polyphenolic Acetates in a Human Glioma Cell Line (BMG-1)
Current Pharmaceutical Design Manufacturing of [<sup>14</sup>C]-Labeled Drug Substance and Drug Product Utilized in Clinical Research: A Case Study of Omecamtiv Mecarbil
Current Pharmaceutical Design EGF Receptor as a Drug Target in Arterial Hypertension
Mini-Reviews in Medicinal Chemistry Design and Synthesis of Thiazolidinedione Derivates as Selective PPARγ Modulators
Letters in Drug Design & Discovery Resveratrol-Mediated Reversal of Tumor Multi-Drug Resistance
Current Drug Metabolism Comparative Effect of Telmisartan vs Lisinopril on Blood Pressure in Patients of Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Evaluation of the Prevalence of Sleep Disorder Among Patients with Type 2 Diabetes Mellitus Referring to Ghaem Hospital from 2016 to 2017
Current Diabetes Reviews